Using short‐term response information to facilitate adaptive randomization for survival clinical trials
- 26 March 2009
- journal article
- research article
- Published by Wiley in Statistics in Medicine
- Vol. 28 (12), 1680-1689
- https://doi.org/10.1002/sim.3578
Abstract
Increased survival is a common goal of cancer clinical trials. Owing to the long periods of observation and follow‐up to assess patient survival outcome, it is difficult to use outcome‐adaptive randomization in these trials. In practice, often information about a short‐term response is quickly available during or shortly after treatment, and this short‐term response is a good predictor for long‐term survival. For example, complete remission of leukemia can be achieved and measured after a few cycles of treatment. It is a short‐term response that is desirable for prolonging survival. We propose a new design for survival trials when such short‐term response information is available. We use the short‐term information to ‘speed up’ the adaptation of the randomization procedure. We establish a connection between the short‐term response and the long‐term survival through a Bayesian model, first by using prior clinical information, and then by dynamically updating the model according to information accumulated in the ongoing trial. Interim monitoring and final decision making are based upon inference on the primary outcome of survival. The new design uses fewer patients, and can more effectively assign patients to the better treatment arms. We demonstrate these properties through simulation studies. Copyright © 2009 John Wiley & Sons, Ltd.Keywords
This publication has 31 references indexed in Scilit:
- Optimal adaptive randomized designs for clinical trialsBiometrika, 2007
- Impact of phase II trials with progression-free survival as end-points on survival-based phase III studies in patients with anaplastic gliomasBMC Cancer, 2007
- Response-Adaptive Randomization for Survival Trials: The Parametric ApproachJournal of the Royal Statistical Society Series C: Applied Statistics, 2007
- Bayesian adaptive designs for clinical trialsBiometrika, 2005
- Bayesian randomized clinical trials: A decision‐theoretic sequential designThe Canadian Journal of Statistics / La Revue Canadienne de Statistique, 2004
- Can the pharmaceutical industry reduce attrition rates?Nature Reviews Drug Discovery, 2004
- Bayesian Statistics and the Efficiency and Ethics of Clinical TrialsStatistical Science, 2004
- A Case Study of an Adaptive Clinical Trial in the Treatment of Out-Patients with Depressive DisorderJournal of the American Statistical Association, 1994
- Optimal two-stage designs for phase II clinical trialsControlled Clinical Trials, 1989